Immunogenicity of meningococcal polysaccharide conjugate vaccine as a replacement for meningococcal polysaccharide vaccine in children in Guangzhou, China

被引：2
|
作者：
He, Qing [1 ]
Xiao, Jiali [2 ]
Liu, Meizhen [3 ]
Li, Zhencui [3 ]
Xu, Jiangxiong [1 ]
Zhang, Zhoubin [1 ]
机构：
[1] Guangzhou Ctr Dis Control & Prevent, Guangzhou 510440, Peoples R China
[2] Guangzhou Tianhe Ctr Dis Control & Prevent, Guangzhou 510655, Peoples R China
[3] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou 511430, Peoples R China
来源：
VACCINE | 2022年 / 40卷 / 09期
关键词：
vaccine; Meningococcal polysaccharide vaccine; Immunogenicity; Persistence; Meningococcal polysaccharide conjugate vaccine; PREVENTION; DISEASE;
D O I：
10.1016/j.vaccine.2021.09.021
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
To assess the durability of antibody persistence after substitution of the MPCV vaccine for the MPSV-A vaccine in children, an observational study was conducted in children who voluntarily received two doses of MPCV-AC instead of MPSV-A between March 2017 and March 2018 in Guangzhou, China. In total, 131 and 47 participants were enrolled in the 3-year-old and 6-year-old groups, respectively. In the 3-year-old group, the seroprotection rate and GMT values for Men A and Men C were raised significantly after 1 month post-dose 1 MPSV booster vaccination. All immune indicators were significantly lower in pre dose 1 MPSV booster vaccination in the 3-year-old group than after pre-dose 2 MPSV booster vaccination in the 6-year-old group. While no significant differences were found in most immune indicators between the 1-month post-dose 1 MPSV booster vaccination in the 3-year-old group and pre-dose 2 MPSV booster vaccination in 6-year-old group. The substitute meningococcal immunization schedule showed a good immunogenicity in young children, and good sequential immunogenicity with MPSV booster immunization. (c) 2021 Published by Elsevier Ltd.
引用
收藏
页码：1370 / 1375
页数：6
相关论文
共 50 条
  • [21] Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A + C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial
    Choo, S
    Zuckerman, J
    Goilav, C
    Hatzmann, E
    Everard, J
    Finn, A
    VACCINE, 2000, 18 (24) : 2686 - 2692
  • [22] Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans
    Sow, Samba O.
    Okoko, Brown J.
    Diallo, Aldiouma
    Viviani, Simonetta
    Borrow, Ray
    Carlone, George
    Tapia, Milagritos
    Akinsola, Adebayo K.
    Arduin, Pascal
    Findlow, Helen
    Elie, Cheryl
    Haidara, Fadima Cheick
    Adegbola, Richard A.
    Diop, Doudou
    Parulekar, Varsha
    Chaumont, Julie
    Martellet, Lionel
    Diallo, Fatoumata
    Idoko, Olubukola T.
    Tang, Yuxiao
    Plikaytis, Brian D.
    Kulkarni, Prasad S.
    Marchetti, Elisa
    LaForce, F. Marc
    Preziosi, Marie-Pierre
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (24): : 2293 - 2304
  • [23] Safety and Immunogenicity of a Meningococcal Quadrivalent Conjugate Vaccine in Five- to Eight-Year-Old Saudi Arabian Children Previously Vaccinated with Two Doses of a Meningococcal Quadrivalent Polysaccharide Vaccine
    Khalil, Mohamed
    Al-Mazrou, Yagob
    Findlow, Helen
    Chadha, Helen
    Castells, Valerie Bosch
    Johnson, David R.
    Borrow, Ray
    CLINICAL AND VACCINE IMMUNOLOGY, 2012, 19 (10) : 1561 - 1566
  • [24] Immunogenicity of bivalent AC polysaccharide meningococcal vaccine in children aged 6 through 24 months
    Lebel, MH
    Tapiero, BF
    Saintonge, F
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (12): : 1578 - 1579
  • [25] Is meningococcal polysaccharide vaccine safe during pregnancy?
    Adam, I
    Abdalla, MA
    ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 2005, 99 (06): : 627 - 628
  • [26] Efficacy of serogroup C meningococcal polysaccharide vaccine
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 1998, 14 (03) : 590 - 595
  • [27] IMMUNOGENICITY OF MENINGOCOCCAL-A AND MENINGOCOCCAL-C CONJUGATE VACCINE IN ADULTS
    BOWERS, T
    ANDERSON, E
    BELSHE, RB
    KENNEDY, D
    SIROTA, N
    MINK, CM
    CLINICAL RESEARCH, 1993, 41 (03): : A650 - A650
  • [28] Immunogenicity of a tetravalent meningococcal polysaccharide vaccine in a single company of marine recruits.
    Patel, S
    Hale, B
    Granoff, D
    JOURNAL OF INVESTIGATIVE MEDICINE, 2004, 52 (01) : S129 - S129
  • [29] Specificity of the immune response to a modified group B meningococcal polysaccharide conjugate vaccine
    Moore, Samuel
    Farley, Esme K.
    Fusco, Peter C.
    Michon, Francis
    CLINICAL AND VACCINE IMMUNOLOGY, 2007, 14 (01) : 106 - 109
  • [30] Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine
    Robertson, Corwin A.
    Greenberg, David P.
    Hedrick, James
    Pichichero, Michael
    Decker, Michael D.
    Saunders, Martha
    VACCINE, 2016, 34 (44) : 5273 - 5278
12345